Aardvark Therapeutics, Inc.
AARD
$11.75
-$0.064-0.54%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 03/31/2024 | ||
|---|---|---|---|---|---|
| Net Income | -9.31M | -8.78M | -4.18M | -2.18M | |
| Total Depreciation and Amortization | 5.00K | -121.00K | 87.00K | 2.00K | |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | |
| Total Other Non-Cash Items | 274.00K | 358.00K | 236.00K | 305.00K | |
| Change in Net Operating Assets | -2.36M | 815.00K | -96.00K | -319.00K | |
| Cash from Operations | -11.39M | -7.73M | -3.96M | -2.19M | |
| Capital Expenditure | -- | -6.00K | -5.00K | -5.00K | |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | -112.62M | -11.89M | -- | -- | |
| Cash from Investing | -112.62M | -11.90M | -5.00K | -5.00K | |
| Total Debt Issued | -- | -- | -- | -- | |
| Total Debt Repaid | -- | -- | -- | -- | |
| Issuance of Common Stock | 91.19M | 163.00K | 169.00K | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | |
| Issuance of Preferred Stock | -- | 0.00 | 0.00 | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | -2.31M | -1.18M | -105.00K | -- | |
| Cash from Financing | 88.88M | -1.01M | 64.00K | -- | |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | -35.14M | -20.64M | -3.90M | -2.20M | |